Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder

Journal of Clinical Psychiatry

Volumn 57, Issue 4, 1996, Pages 147-151

  Keck Jr , Paul E ^a,b   McElroy, Susan L ^a   Strakowski, Stephen M ^a   Balistreri, Tony M ^a   Kizer, Danielle L ^a   West, Scott A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Biological Psychiatry Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPENTIXOL DECANOATE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 0029928892     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Baldessarini RJ. Chemotherapy in Psychiatry. Cambridge, Mass. Harvard University Press; 1985
2. Hopkins HS, Gelenberg AJ. Treatment of bipolar disorder: how far have we come? Psychopharmacol Bull 1994;30:27-38
3. Keck PE Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405
4. Hirschfeld RMA, Clayton PJ, Cohen I, et al. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(suppl):1-31
5. Kane JM. The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 1988;49(11, suppl):12-13
6. Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors. Arch Gen Psychiatry 1982;39:473-481
7. Wegner JT, Catalano F, Gibralter J, et al. Schizophrenics with tardive dyskinesia. Arch Gen Psychiatry 1985;42:860-865
8. Mukherjee S, Rose AM, Caracci G, et al. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986;43:342-346
9. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of manic-depressive cycle and changes caused by treatments. Pharmakopsychiatr 1980; 13:156-167
10. Esparon J, Kollaori J, Naylor GJ, et al. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry 1986;148:723-725
11. White E, Cheung P, Silverstone T. Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 1993;8:119-122
12. Hendrick V, Altshuler LL, Szuba MP. Is there a role for neuroleptics in bipolar depression? J Clin Psychiatry 1994;55:533-535
13. Sachs GS. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry 1990:51 (5, suppl):31-34
14. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-135
15. Naylor GJ, Scott CR. Depot injections for affective disorders [letter]. Br J Psychiatry 1980;136:105
16. Lowe MR, Batchelor DH. Depot neuroleptics and manic depressive psychosis. Int Clin Psychopharmacol 1986;1(suppl):53-62
17. Lowe MR, Batchelor DH. Lithium and neuroleptics in the management of manic depressive psychosis. Human Psychopharmacology 1990;5: 267-274
18. Ahlfors UG, Baastrup PC, Dencker SJ, et al. Flupenthixol decanoate in recurrent manic-depressive illness. Acta Psychiatr Scand 1981;64: 226-237
19. Keck PE Jr, McElroy SL, Strakowski SM, et al. Outcome and comorbidity in first compared with multiple episode mania. J Nerv Ment Dis 1995; 183:320-324
20. McElroy SL, Strakowski SM, Keck PE Jr, et al. Differences and similarities in mixed and pure mania. Compr Psychiatry 1995;36:189-194
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition, Revised. Washington, DC: American Psychiatric Press; 1987
22. Strakowski SM, Keck PE Jr, McElroy SL, et al. Chronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatry 1995;36:106-112
23. Spitzer RL, Williams JBW, Gibbon M, et al. The Structured Clinical Interview for DSM-III-R, I: history, rationale, and description. Arch Gen Psychiatry 1992;49:624-629
24. Williams JBW, Gibbon M, First MB, et al. The Structured Clinical Interview for DSM-III-R (SCID). II: multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630-636
25. Young RC, Biggs JT, Ziegler VE, et al. Among scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-435
26. Hamilton M. A rating scale for depression J Neurol Neurosurg Psychiatry 1960;23:56-62
27. Andreasen NC. Scale for the Assessment of Positive Symptoms. Iowa City. Iowa: University of Iowa College of Medicine; 1982
28. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press, 1990
29. McElroy SL, Dessain EC, Pope HG Jr. et al Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-414
30. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting; May 31-June 3, 1995; Orlando. Fla. Abstract No 8
31. Dwight MM, Keck PE Jr, Stanton SP, et al. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 1994;344:555-556
32. Keck PE Jr, Wilson DR, Strakowski SM, et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995;56:466-470
33. Cochran SD. Compliance with lithium regimens in the outpatient treatment of bipolar affective disorders. Journal of Compliance With Health Care 1986;1:153-170